Sabra's SHOP Engine Is Humming. So Why Is Management Shrugging at Pricing Power?

Q3 delivered 8% FFO/AFFO growth and a $1.17B pipeline, but the occupancy-to-pricing playbook got a cautious rewrite — and skilled nursing quietly became a growth story again.

SBRA · Earnings Call · 2026-11-03

The Beat Was Real; the Story Was More Complicated

Sabra's third quarter looked like a clean continuation of the senior-housing operating turnaround. Normalized FFO per share was $0.39 and normalized AFFO $0.41, each up 8% year over year, and management nudged the midpoint of 2026 guidance higher by $0.005 — implying 7% FFO growth and 8% AFFO growth for the year. Same-store SHOP cash NOI rose 14.6%, revenue 9.3%, occupancy 160 basis points to 89.2%, and RevPAR growth was 7.3%. The 34.9% same-store SHOP cash NOI margin is, in CEO Rick Matros's words, "best in class." The external engine is also running: $750 million of investments closed year to date, $425 million awarded, and more than $1.17 billion closed plus awarded. “In addition to the over $1.17 billion in closed and awarded investments, Sabra has an additional $260 million of SHOP investments that we are actively pursuing.” — Darrin L. Smith, Senior Housing Operating Portfolio Executive or similar · 2026-11-03 That is a real awarded pipeline, not a slide-deck promise. Yet the stock tells a more guarded story: shares are up 4.3% over the last 90 days but remain 9.1% below the July 27 peak of $22.39, and the full history still sits 40.2% below the 2015 high. The market has noticed the operating recovery; it has not fully re-rated the equity.

The Pricing-Power Pushback

The most interesting moment on the call was not the beat. It was management's refusal to embrace the sector's favorite occupancy-to-pricing syllogism. When asked whether above-90% occupancy is translating into rate power, CFO Michael Costa was blunt: “we are not seeing any evidence of that within our portfolio, at least not yet.” — Michael Lourenco Costa, Chief Financial Officer · 2026-11-03 He attributed the strong RevPAR number instead to acuity — operators taking higher-acuity residents and charging for the care — rather than to broad pricing leverage. Rick later reinforced the point: once you get into the low nineties, the intuitive assumption is that pricing power arrives, but "we are just not there yet on occupancy." This is a meaningful rhetorical shift. In August, the company described its RevPAR growth as "the natural growth of occupancy and efficiency and a little bit of pricing power." “It's just the natural growth of occupancy and efficiency and a little bit of pricing power.” — Rick Matros, Chief Executive Officer (CEO) · 2026-08-03 And in February, the message was more optimistic still: “as occupancy continues to increase. There will be more pricing power, and we should see some elevated growth at that point.” — Elmer Chang, Unknown · 2026-02-13 So the current quarter marks a more conservative framing of the same pricing power theme — not a denial that it can arrive, but a refusal to bank on it before the occupancy data prove it. That matters because one healthcare REIT peer spent its own call touting deep pricing power. Sabra is effectively saying: not so fast, at least not in our senior-housing portfolio. The upside case remains intact, but the timing has been pushed out.

Skilled Nursing: From Legacy Drag to Contractual Growth

The second storyline is the rehabilitation of the skilled portfolio. For years Sabra was a skilled-nursing REIT trying to become a SHOP company. This quarter, management spent real time explaining why the remaining skilled assets are a source of contractual earnings growth, not just a shrinking percentage of the mix. The key lever is lease expirations: Rick said the company has a big chunk of leases coming due between 2027 and 2031 and expects to reset rents toward fair market because coverage is so far above typical levels. “We have got between 2027 and ... 31. We have a big chunk of leases coming up, so you should expect us to take advantage of that.” — Richard K. Matros, Chief Executive Officer · 2026-11-03 The specific leases under discussion carry coverage "well over 2x," “They are well over 2x.” — Richard K. Matros, Chief Executive Officer · 2026-11-03 and the Avamere transition took annualized rent from $48 million to $53 million, with the full benefit landing in 2027. This is not a new theme — rent resets and transitions have appeared in prior calls — but the emphasis has changed. The company is now framing skilled nursing as a hedge against SHOP cap-rate compression, not merely a legacy asset to prune.

We want to have a very well balanced portfolio. We like the idea of having more SHOP than skilled. But ... we just do not wanna make a bet just on 1 asset class only, particularly with the contributions that we are getting out of the skilled portfolio now.
Richard K. Matros, Chief Executive Officer · 2026-11-03

That is a subtle but important moderation of the pure SHOP-maximalist narrative. Sabra still expects SHOP to approach 50% of the portfolio by year-end 2027, but management no longer sounds like it wants to win that transition at any cost.

Funding, Pipeline, and the Missing AI Story

The balance sheet supports the growth plan without much drama. Net debt to adjusted EBITDA was 4.54x, down from 4.61x, and liquidity was roughly $1.2 billion. The last filed quarter showed $86 million of operating cash flow, up 6% year over year, while liabilities to assets sat at 50.1%. The funding stack includes forward ATM shares and revolver capacity, and management says it has enough capital to close the current pipeline through early 2027. The economics are decent: the total closing awarded pipeline has a Year 1 yield in the low 7s, with stabilized yields around 8% on SHOP investments, even as cap-rate pressure on senior housing has moderated with higher rates. One theme that has oddly fallen away is AI initiatives. Earlier this year, automation and prop-tech were a headline efficiency story; on this call, they surfaced only in Q&A, with management calling the corporate cost "really incremental" and framing AI as a scalability tool rather than a near-term margin lever. The other regulatory bogeyman, the federal staffing mandate, was similarly dismissed: every state where Sabra operates already has staffing rules, and management said the federal proposal was more noise than impact. Those are not bearish data points — but they do suggest the story is no longer about new narratives. It is about executing the old ones: filling beds, pushing acuity, resetting skilled rents, and proving that the pricing-power option eventually becomes real.